Thimerosal Attenuates Ischaemia-Reperfusion Arrhythmias in Rats: No Modification by Anti-Ischaemic Agent Trimetazidine or Endothelin Receptor Antagonist Bosentan

Author： Iskit A.B.   Oguz Guc M.  

Publisher： Academic Press

ISSN： 1043-6618

Source： Pharmacological Research, Vol.34, Iss.1, 1996-07, pp. : 17-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Beneficial effects of the endothelin receptor antagonist bosentan on myocardial and endothelial injury following ischaemia/reperfusion in the rat

By Xing-San L.   Qing-Dong W.   John P.  

European Journal of Pharmacology, Vol. 283, Iss. 1, 1995-09 ,pp. : 161-168

Elsevier

Access to resources Recommend Favorite

Trimetazidine Ameliorates the Hepatic Injury Associated with Ischaemia–reperfusion in Rats

By Settaf A.   Morin D.   Lamchouri F.   Elimadi A.   Cherrah Y.   Tillement J-P.  

Pharmacological Research, Vol. 39, Iss. 3, 1999-01 ,pp. : 211-216

Academic Press

Access to resources Recommend Favorite

Bosentan: a dual endothelin receptor antagonist

By Roux Sébastien   Rubin Lewis J  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 7, 2002-07 ,pp. : 991-1002

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacology of Bosentan, a Dual Endothelin Receptor Antagonist

By Jasper Dingemanse   Paul L.M. van Giersbergen  

Clinical Pharmacokinetics, Vol. 43, Iss. 15, 2004-01 ,pp. : 1089-1115

Adis International

Access to resources Recommend Favorite

Coronary and aortic vasoreactivity protection with endothelin receptor antagonist, bosentan, after ischemia and hypoxia in aged rats

By Besse S.   Tanguy S.   Riou B.   Boucher F.   Bulteau A.-L.   Le Page C.   Swynghedauw B.   de Leiris J.  

European Journal of Pharmacology, Vol. 432, Iss. 2, 2001-12 ,pp. : 167-175

Elsevier

Access to resources Recommend Favorite